Cannabis Science Releases Worldwide Growth Guidance For Its Formulations Targeting Critical Ailment

A pioneering US biotech company developing pharmaceutical cannabis products, is pleased to release its analysis of the worldwide market potential for medical cannabis treatments of critical ailments. The actual worldwide market for treating critical ailments with Cannabis formulation amounts to trillions of dollars.

The Company works with world authorities on science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

List of illnesses that can be trated with medical cannabis:

Skin cancer (basal cell carcinoma)

Breast cancer (Ductal carcinoma)

Colon glioma (brain tumor)

Lung cancer

Bone Marrow Cancer (multiple myeloma)

Ovarian

Pheochromocytoma

Prostate cancer

Skin Cancer (squamous cell carcinoma)

Medical and Health Care Investors

We are dedicated to the creation of cannabis-based medicines to treat disease and the symptoms of disease, as well as for general health maintenance, and we are looking for investors to help provide excellent and efficient medical and health care for our future researches. Your help can make a great difference in people's lives, we welcome you to contact us for more information.

For more information, please visit
http://www.cskillscancer.com